Alternative splicing has been demonstrated to have a key role in cancer development, and data indicate that alternative splicing of key genes such as BCL2L1 [6], RON [7] and FOX2 [8] can drive a cancer phenotype. The gene discussed is RBFOX2; the disease is cancer.